Brief: N4 Pharma H1 Basic EPS GBP -0.0009
25/09/2025 07:00
Sep 25 (Reuters) - N4 Pharma H1 EPS GBP -0.0009.
Recent news on Thalia Therapeutics
See all newsThalia Therapeutics - Interim Results
Brief: Thalia Therapeutics Says New Patent Granted For Miristen In China
Thalia Therapeutics - New Patent Granted for miRisten in China
Thalia Therapeutics - RNA gene-silencing cardiovascular program advances
Thalia Therapeutics - Business Update and Notice of Results